Skip to Main Content
Try STAT+ TODAY
Trending:
Pharmalot
Coronavirus
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

‘Every man and his dog’ does cell therapy. Vor’s new CEO says the company wants to be different

  • Kate Sheridan

By Kate Sheridan Aug. 7, 2019

Reprints
Human T lymphocyte
Scanning electron micrograph of a T cell from the immune system of a healthy donor. NIAID

Three years after Pulitzer Prize-winning writer and oncologist Dr. Siddhartha Mukherjee founded Vor Biopharma, the company finally has its first executive.

Robert Ang, formerly the chief business officer for Neon Therapeutics, will be Vor’s first chief executive officer, the company announced Wednesday.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Kate Sheridan

Kate Sheridan

Research Reporter

Kate collects and analyzes documents, data, and other information for biotech, health tech, science, and politics stories.

Tags

Judge rules CVS, Walgreens, and Walmart owe $650M in…
Judge rules CVS, Walgreens, and Walmart owe $650M in opioids suit
In an effort to address its missteps during Covid,…
In an effort to address its missteps during Covid, CDC plans an ‘ambitious’ agency overhaul
8 movies that really got science wrong
8 movies that really got science wrong
Pharma’s likely to sue over Medicare negotiation. Here are…
Pharma’s likely to sue over Medicare negotiation. Here are the arguments they might use
Bluebird wins U.S. approval for a gene therapy to…
Bluebird wins U.S. approval for a gene therapy to treat patients with a rare blood disorder
‘A blind eye’: NIH fails to ensure clinical trial…
‘A blind eye’: NIH fails to ensure clinical trial results are reported, and still funds researchers…

Recommended Stories